178 related articles for article (PubMed ID: 29105189)
21. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
22. Xenobiotics, chimerism and the induction of tolerance following organ transplantation.
Delaney CP; Thomson AW; Demetris AJ; Starzl TE
Ther Immunol; 1994 Jun; 1(3):153-64. PubMed ID: 7584491
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y
J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196
[TBL] [Abstract][Full Text] [Related]
24. Chimerism studies as an approach for the induction of tolerance to extremity allografts.
Muramatsu K; Kuriyama R; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1009-15. PubMed ID: 18573704
[TBL] [Abstract][Full Text] [Related]
25. Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
Oura T; Cosimi AB; Kawai T
Clin Exp Immunol; 2017 Aug; 189(2):190-196. PubMed ID: 28369830
[TBL] [Abstract][Full Text] [Related]
26. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
[TBL] [Abstract][Full Text] [Related]
27. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2009 Nov; 70(5):423-30. PubMed ID: 19874546
[TBL] [Abstract][Full Text] [Related]
28. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
30. Immune tolerance induced by donor antigen and cyclophosphamide in rat fetal small bowel transplantation.
Nakao M; Taguchi T; Ogita K; Nishimoto Y; Suita S
Fukuoka Igaku Zasshi; 2005 Feb; 96(2):49-57. PubMed ID: 15852663
[TBL] [Abstract][Full Text] [Related]
31. Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance.
Xie Y; Wu Y; Xin K; Wang JJ; Xu H; Ildstad ST; Leventhal J; Yang GY; Zhang Z; Levitsky J
Transplantation; 2017 May; 101(5):1056-1066. PubMed ID: 28187014
[TBL] [Abstract][Full Text] [Related]
32. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
33. Reflections on the unique tolerogenicity of bone marrow, the enigma of chimerism and clinical tolerance.
Monaco AP
Clin Transpl; 2013; ():157-66. PubMed ID: 25095504
[TBL] [Abstract][Full Text] [Related]
34. The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs.
Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
J Orthop Res; 2006 Nov; 24(11):2133-40. PubMed ID: 16944471
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Sueishi K; Nomoto K; Yasui H
Scand J Immunol; 2005 Sep; 62(3):271-80. PubMed ID: 16179014
[TBL] [Abstract][Full Text] [Related]
36. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates.
Bashuda H; Kimikawa M; Seino K; Kato Y; Ono F; Shimizu A; Yagita H; Teraoka S; Okumura K
J Clin Invest; 2005 Jul; 115(7):1896-902. PubMed ID: 15951837
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
[TBL] [Abstract][Full Text] [Related]
39. Prolongation of kidney graft survival by cyclophosphamide-induced tolerance in rats.
Eto M; Nishimura Y; Matsuo K; Omoto K; Goto K; Kumuzawa J; Nomoto K
J Urol; 1995 May; 153(5):1693-6. PubMed ID: 7715012
[TBL] [Abstract][Full Text] [Related]
40. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
